does metformin prevent short term oxidant-induced dna damage? in vitro study on lymphocytes from aged subjects

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 18, Issue 2, 2007, Pages 129-140

  Kanigür Sultuybek, Gönül ^a   Onaran, Ilhan ^a   Ozdas, Sule Beyhan ^b   Curgunlu, Ash ^a   Tezcan, Vecdet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

comet assay; DNA damage; lymphocyte; metformin; oxidative stress

Indexed keywords

CELL DNA; DNA FRAGMENT; METFORMIN; OXIDIZING AGENT;

ADULT; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; FEMALE; HUMAN; IN VITRO STUDY; LYMPHOCYTE; MALE; NORMAL HUMAN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; APOPTOSIS; BENZENE DERIVATIVES; COMET ASSAY; DNA BREAKS; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LYMPHOCYTES; MALE; METFORMIN; OXIDATIVE STRESS;

EID: 34547639301     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2007.18.2.129     Document Type: Article

References (33)

1. Mercuri, F, Quagliaro, L and Ceriello, A. Oxidative stress evaluation in diabetes. Diabetes Technol Ther 2000;2:589–600.
2. Sohal, RS. The free radical hypothesis of aging; an appraisal of the current status. Aging (Milano) 1993;5:3–17.
3. Ames, BN. Mutagenesis and carcinogenesis; endogenous and exogenous factors. Environ Mol Mutagen 1989;14 Suppl 16:66–77.
4. Dincer, Y, Akcay, T, Alademir, Z and Ilkova, H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res 2002;29:75–81.
5. Pitozzi, V, Giovannelli, L, Bardini, G, Rotella, CM and Dolara, P. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res 2003;529:129–33.
6. Ceriello, A: New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 2003;26:1589–96.
7. Grant, PJ. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 2003;29:6844–52.
8. Wiemsperger, NF. Metformin: intrinsic vasculoprotective properties. Diabetes Technol Ther 2000;2:259–72.
9. Faure, P, Rossini, E, Wiemsperger, N, Richard, MJ, Favier, A, Halimi, S. An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes 1999;48: 353–57.
10. Kanigur-Sultuybek, G, Guven, M, Onaran, I, Tezcan, V, Cenani, A, Hatemi, H: The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocininduced diabetes. J Basic Clin Physiol Pharmacol 1995;6:271–80.
11. Bonnefont-Rousselot, D, Raji, B, Walrand, S, Gardes-Albert, M, Jore, D, Legrand, A, et al. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 2003;52:586–89.
12. Onaran, I, Guven, GS., Ozdaş, SB, Kanigur, G, Vehid, S. Metformin does not prevent DNA damage in lymphocytes despite its antioxidant properties against cumene hydroperoxide-induced oxidative stress. Mutat Res 2006;611:1–8.
13. Hannon-Fletcher, MPA, O’Kane, MJ, Moles, KW, Weatherup, C, Barnett, CR, Barnett, YA. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat Res 2000; 460:53–60.
14. Rattan, SI. DNA damage and repair during cellular aging. Int Rev Cytol 1989;116:47–88.
15. Chicca, MC, Nesti, C, Muzzoli, M, Pasetti, P and Pinamonti, S. Correlation between age and DNA damage detected by FADU in human peripheral blood lymphocytes. Mutat Res 1996;316:201–8.
16. Tice, RR, Setlow, RB. DNA repair and replication in aging organisms and cells. In: Florini J, R, Adelman, RC, Roth, GS, eds. Handbook of biochemistry in aging Boca Raton, FL, USA: CRC Press, 1985;25–48.
17. Anisimov, VN, Berstein, LM, Egormin, PA, Piskunova, TS, Popovich, IG, Zabezhinski, MA, et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 2005;40:685–93.
18. Yuen, KH, Khiang, PK. Simple high-performance liquid chromatographic method for the determination of metformin in human plasma. J Chromatogr B Biomed Sci 1998:12;243–46.
19. Singh, NP, McCoy, MT, Tice, RR, Schneider, E. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184–91.
20. Tice, RR, Strauss, GH. The single cell gel electrophoresis/comet assay: a potential tool for detecting radiation-induced DNA damage in humans. Stem Cells 1995;13 Suppl 1:207–14.
21. Anderson, D, Yu, TW, Phillips, BJ. Schmerzer, P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the Comet assay. Mutat Res 1994;30:261–71.
22. Diem, E, Ivancsits, S, Rudiger, HW: Basal levels of DNA strand breaks in human leukocytes determined by comet assay. J Toxicol Environ Health 2002;65:641–8.
23. Wei, YH. Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med 1998;217:53–63.
24. King, CM, Bristow-Craig, HE, Gillespie, ES, Barnett, YA. In vivo antioxidant status, DNA damage, mutation and DNA repair capacity in cultured lymphocytes from healthy 75-to 80-year-old humans. Mutat Res 1997;377:137–47.
25. Mendoza-Nunez, VM, Retana-Ugalde, R, Sanchez-Rodriguez, MA, Altamirano-Lozano, MA. DNA damage in lymphocytes of elderly patients in relation with total antioxidant levels. Mech Ageing Dev 1999;108;9–23.
26. Mutlu-Turkoglu, U, Ilhan, E, Oztezcan, S, Kuru, A, Aykac-Toker, G, Uysal, M: Age related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 2003;36:397–400.
27. Mecocci, P, Fano, G, Fulle, S, MacGarvey, U, Shinobu, L, Polidori, MC, et al. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med 1999;26:303–8.
28. Wolf, FI, Torsello, A, Covacci, V, Fasanella, S, Montanari, M, Boninsegna, A, et al. Oxidative DNA damage as a marker of aging in WI-38 human fibroblasts. Exp Gerontol 2002:37;647–56.
29. Dilman, VM. Development, aging and disease. A new rationale for an intervention. Chur, Switzerland: Harwood Academic Publishers, 1994
30. Bonnefont-Rousselot, D, Raji, B, Walrand, S, Gardes-Albert, M, Jore, D, Legrand, A, et al. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 2003;52:586–89.
31. Gaikwad, NW, Bodell, WJ. Formation of DNA adducts by microsomal and peroxidase activation of p-cresol: role of quinone methide in DNA adduct formation. Chem Biol Interac 2001;38:217–29.
32. Marchetti, P, Del Guerra, S, Marselli, L, Lupi, R, Masini, M, Pollera, M, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004;89:5535–41.
33. El-Mir, MY, Nogueira, V, Fontaine, E, Avéret, N, Rigoulet, M, Leverve, X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex, I. J Biol Chem 2000;275: 223–8.